Trials / Recruiting
RecruitingNCT06877520
Early Feasibility of 'Pivot Extend' for Tricuspid Regurgitation Treatment
Early Feasibility Study (EFS) of the 'Pivot Extend' in Treatment for Tricuspid Regurgitation (SPACER Study)
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 7 (estimated)
- Sponsor
- Tau-MEDICAL Co., Ltd. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This clinical trial aims to evaluate the safety and demonstrate the efficacy of treatment to improve tricuspid regurgitation (TR) symptoms in patients with severe and clinically symptomatic TR through long-term implantation of an investigational medical device. 1. Determine the safety of long-term implantation of the investigational medical device "Pivot Extend" by monitoring for MACEs associated with the investigational medical device or procedure that may occur with long-term associated with the investigational medical device or procedure that may occur with long-term implantation. 2. Device success, procedural success, and clinical outcomes of long-term implantation of the investigational medical device "Pivot Extend" will be monitored.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Pivot Extend Tricuspid Regurgitation Spacer Device | The Pivot Extend Tricuspid Regurgitation Spacer Device is an investigational implant designed to reduce tricuspid regurgitation (TR) by occupying the regurgitant orifice and improving leaflet coaptation. The device is implanted via a transcatheter procedure under imaging guidance. Following implantation, participants will undergo post-procedural monitoring for at least 24 hours to ensure safety and device stability. The device is intended for long-term placement, with scheduled follow-up assessments at designated intervals over a 12-month period to evaluate its safety and efficacy. Device removal may be performed if adverse events occur or if deemed necessary by the investigator. |
Timeline
- Start date
- 2025-05-01
- Primary completion
- 2026-05-01
- Completion
- 2026-12-01
- First posted
- 2025-03-14
- Last updated
- 2025-04-11
Locations
3 sites across 1 country: Georgia
Source: ClinicalTrials.gov record NCT06877520. Inclusion in this directory is not an endorsement.